Prevention of bacterial colonization on polyurethane in vitro by incorporated antibacterial agent.

The presence of implanted biomaterials increases host susceptibility to infections. Once established, biomaterial-mediated infections are resistant to treatment and persist until the device is removed. The objective of this work was to study the prevention of bacterial-biofilm formation on polymeric implant (polyurethane) by controlled release of incorporated antibacterial agents (parabens). By embedding parabens in PU by the solvent-cast method, matrices with amorphous dispersions (or solid solutions) were obtained. Release rate modulation was achieved by using different MW parabens and by a rate-limiting membrane. Preliminary in vitro antibacterial studies of both methyl and propyl paraben matrices exhibited significant inhibition of Staphylococcus epidermidis biofilm formation. Propyl paraben matrices (15 and 20% w/w drug load) decreased the number of colony-forming units on PU surface to 2 x 10(4)/mL, in comparison to 6 x 10(5) on control polymers. This significant reduction was obtained without any effect on the number of viable bacteria in the suspension culture. This type of delivery system provides regional prophylactic activity by creating a high local concentration of antibacterial agent.

[1]  A. Gristina,et al.  Adherent bacterial colonization in the pathogenesis of osteomyelitis , 2007 .

[2]  Q. Myrvik,et al.  Surgical biomaterials and differential colonization by Staphylococcus epidermidis. , 1988, Biomaterials.

[3]  R. Sherertz,et al.  Antibiotic releasing polymers , 1987 .

[4]  Q. Myrvik,et al.  Adhesive colonization of biomaterials and antibiotic resistance. , 1987, Biomaterials.

[5]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[6]  R. Levy,et al.  Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating. , 1987, Journal of pharmaceutical sciences.

[7]  J. Nickel,et al.  Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material , 1985, Antimicrobial Agents and Chemotherapy.

[8]  G. Golomb,et al.  New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy. , 1983, Journal of periodontal research.

[9]  R. Simmons,et al.  Infections in bionic man: the pathobiology of infections in prosthetic devices-Part II. , 1982, Current problems in surgery.

[10]  G. Golomb,et al.  New sustained release dosage form of chlorhexidine for dental use. I. Development and kinetics of release. , 1982, Journal of periodontal research.

[11]  E. Moxon,et al.  Detection and quantitation of bacteremia in childhood. , 1977, The Journal of pediatrics.

[12]  L. Vistnes,et al.  Iodinated silicone-an antibacterial alloplastic material. , 1977, Plastic and reconstructive surgery.

[13]  S. Yalkowsky,et al.  Mass transport phenomena and models: theoretical concepts. , 1974, Journal of pharmaceutical sciences.

[14]  S. Yalkowsky,et al.  Correlation and prediction of mass transport across membranes. I. Influence of alkyl chain length on flux-determining properties of barrier and diffusant. , 1972, Journal of pharmaceutical sciences.

[15]  S. Yalkowsky,et al.  Importance of chain length on physicochemical and crystalline properties of organic homologs. , 1972, Journal of pharmaceutical sciences.

[16]  J. Anderson,et al.  Sustained release of gentamicin from prosthetic heart valves. , 1979, Transactions - American Society for Artificial Internal Organs.